Luye Pharma Ownership
| LYPHF Stock | USD 0.34 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Luye |
Luye Pink Sheet Ownership Analysis
About 35.0% of the company outstanding shares are owned by corporate insiders. The book value of Luye Pharma was now reported as 2.54. The company last dividend was issued on the 29th of June 2020. Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide. The company was founded in 1994 and is headquartered in Yantai, the Peoples Republic of China. Luye Pharma is traded on OTC Exchange in the United States.The quote for Luye Pharma Group is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Luye Pharma Group learn more at https://www.luye.cn.Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Luye Pink Sheet
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.